| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/10/2001 | US6214318 Comprising mineral oils, vegetable oils, silicone oils or synthetic oils; thickening agents such as waxes to thicken oils to non-flowable state; optionally adjuvants, drugs and emulsifiers and a liquefied propellant; cooling effect |
| 04/10/2001 | CA2081150C Use of antibody-containing preparations for immunosuppression |
| 04/10/2001 | CA2067233C Fibronectin binding peptide |
| 04/10/2001 | CA2027608C Hair revitalizing agent |
| 04/06/2001 | CA2322560A1 Corticoid therapy |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023563A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023391A1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/05/2001 | WO2001023386A2 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023359A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023349A1 Acylsulfonamide derivatives |
| 04/05/2001 | WO2001023006A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | WO2001023003A1 Tissue flap angiogenesis |
| 04/05/2001 | WO2001022973A1 The use of a positively charged carbohydrate polymer for the prevention of infection |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022971A1 Sebum production inhibitors |
| 04/05/2001 | WO2001022959A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 04/05/2001 | WO2001022952A2 Use of tace inhibitors |
| 04/05/2001 | WO2001022923A2 Scar treatment composition |
| 04/05/2001 | WO2001022907A1 Drug delivery of phase changing formulation |
| 04/05/2001 | WO2001008657A3 Personal care articles |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2001005397A8 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 04/05/2001 | WO2001002422A9 PROCESS FOR OBTAINING 17β-(N-TERC-BUTYLCARBAMOYL)-3-ONE-4-AZA-STEROIDS |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 04/05/2001 | WO2000067788A3 Use of soluble costimulatory molecules to enhance immune responses |
| 04/05/2001 | WO2000064474A8 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000040228A3 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | DE19945484A1 NO-freisetzende topisch applizierbare Zusammensetzung NO-releasing topically administrable composition |
| 04/05/2001 | CA2657208A1 Method of treating inflammatory conditions with progesterone of progesterone analogs |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2388005A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2385887A1 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385865A1 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine a3 receptor affinitive agents |
| 04/05/2001 | CA2385493A1 Sebum production inhibitors |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384509A1 Scar treatment composition |
| 04/05/2001 | CA2384265A1 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | CA2382892A1 Substituted benzimidazol derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 04/04/2001 | EP1088823A1 Fused pyrrolocarbazoles |
| 04/04/2001 | EP1088548A2 Use of alverine for reducing wrinkles |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087971A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087970A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087780A1 Extraction method, pharmaceutical composition and a cosmetic composition |
| 04/04/2001 | EP1087768A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 04/04/2001 | EP1087747A1 Foaming composition for hair care |
| 04/04/2001 | EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290180A Sterile complex of therapeutic peptide bond to polysaccharide |
| 04/04/2001 | CN1290172A Topical composition containing human epidermal growth factor |
| 04/04/2001 | CN1290165A Benzothiazole Protein tyrosine kinase inhibitors |
| 04/04/2001 | CN1289620A Liquid medicine for radically treating wart |
| 04/04/2001 | CN1289616A Medicine for treating osteoporosis and its preparing process |
| 04/04/2001 | CN1289600A Medicine for treating scald and wound |
| 04/04/2001 | CN1289595A Injection for treating clavus |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/04/2001 | CN1063967C Oral medicine for curing dermatosis |
| 04/04/2001 | CN1063943C Pharmaceutical compositions containing aminoglycosidic antibiotic, suitable for the topical administration |
| 04/03/2001 | US6211393 Radicals linked to si are si--o--c, si--s--c or si--n--c type bonds and are hydrolyzable in vivo, forming si--oh bonds that are biologically active especially when in contact with living tissue |
| 04/03/2001 | US6211368 Hydrolysis of corresponding ester |
| 04/03/2001 | US6211249 Polyester polyether block copolymers |
| 04/03/2001 | US6211243 Methods for treating cold sores with anti-infective compositions |
| 04/03/2001 | US6211228 Compositions and methods for treating mast-cell mediated conditions |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211188 Treatment of skin disorders |
| 04/03/2001 | US6211167 Arylsulfonanilide phosphates |
| 04/03/2001 | US6211155 Stimulating immune system with peptides conjugated with mono-or dicarboxylic acid; |
| 04/03/2001 | US6211147 Method of promoting angiogenesis using relaxin |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210670 Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin |
| 04/03/2001 | US6210660 Cosmetic preparation containing Ilex resin method for obtaining Ilex resin and Ilex resin which can be obtained by this method |
| 04/03/2001 | CA2035656C Sal olein, a process for its preparation and cosmetic compositions containing it |
| 04/03/2001 | CA2028287C Benzocycloalkylaminopyridinamines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 04/03/2001 | CA2023951C N-hydroxy-dibenz¢b,e!oxepin -alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments |
| 03/30/2001 | WO2003044525A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease |
| 03/30/2001 | WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021761A2 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |